help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mercurio, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mercurio, A. M.
(American Journal of Pathology. 2002;161:3-6.)
© 2002 American Society for Investigative Pathology

Commentaries

Lessons from the {alpha}2 Integrin Knockout Mouse

Arthur M. Mercurio

From the Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

The {alpha}2ß1 integrin (VLA-2), one of the first integrins to be identified and characterized, is a collagen receptor, although it can function as a dual collagen/laminin receptor on some cell types.1 Numerous studies have implicated this integrin in a range of biological and pathobiological functions.2,3 A more rigorous analysis of {alpha}2ß1 function has been hindered, however, by the lack of an {alpha}2-deficient mouse. Given that mice with null mutations in other well-studied integrins that are related to {alpha}2ß1 in either their expression pattern or function [{alpha}1 ({alpha}1ß1);{alpha}3 ({alpha}3ß1); and {alpha}6 ({alpha}6ß1; {alpha}6ß4)] have been available for several years and have provided considerable insight into the function of these integrins, this situation was rather surprising. Fortunately, this issue has been remedied. In this issue of The American Journal of Pathology, Zutter and colleagues report the generation and initial characterization of an {alpha}2-deficient mouse.4 Eckes and colleagues have published similar results recently.5

Surprisingly, or not surprisingly, depending on your preconceived notions, mice deficient in the {alpha}2 subunit are quite healthy. They are viable at birth, develop normally, and are able to reproduce. Their major organs appear to be normal, at least at the level of gross histology. The overt normality of these mice, however, did not deter Zutter and colleagues from probing more deeply into their biology, using the in vitro studies on {alpha}2ß1 as their guide. Their observations are of considerable interest because they both confirm and refute these previously published studies, and they suggest specific areas for future work. A discussion of the phenotype of these mice and their use in future studies, however, warrants a broader discussion on collagen receptors and their relationship to {alpha}2ß1, as well as mention of the caveats associated with the interpretation of results from integrin null mice.

Collagen Receptors

Cellular interactions with and remodeling of collagen matrices, mediated by specific receptors, underlie a multitude of biological and pathobiological processes. Integrins represent one class of collagen receptors. In addition to {alpha}2ß1, four other integrins function as collagen receptors ({alpha}1ß1,{alpha}3ß1, {alpha}10ß1, and {alpha}11ß1).6 These five integrin collagen receptors are distinguished by a common structural feature: the presence of an I (inserted) domain in their {alpha} subunits that mediates collagen binding.6,7 Subtle differences in I domain structure among these integrins may account for the fact that these integrins differ in their ability to recognize distinct collagen subtypes.8 For example, the {alpha}2 I domain binds much better to fibrillar collagens (I-III) than to collagen IV. In contrast, the {alpha}1 and {alpha}10 I domains bind to collagen IV and VI preferentially. Such differences in collagen binding specificity are relevant to the interpretation of data obtained from the analysis of mice deficient in the expression in one of the collagen-binding, integrin {alpha} subunits.

Another important feature of the integrin collagen receptors that needs to be considered with respect to the analysis of knockout mice is that they exhibit distinct patterns of tissue expression. {alpha}1ß1 is expressed primarily on cells of mesenchymal origin including fibroblasts, smooth muscle cells, and microvascular endothelial cells.9 {alpha}2ß1 is expressed on epithelial cells, endothelial cells, fibroblasts, and cells of hematopoietic origin.10 Interestingly, mice deficient in {alpha}1 expression are also viable and rather healthy, although they have defects in collagen synthesis and tumor angiogenesis.11,12 It will be informative to generate mice deficient in the expression of both the {alpha}1 and {alpha}2 subunits given that {alpha}1ß1 and {alpha}2ß1 are co-expressed in several cell types yet interact preferentially with distinct collagens. The a3ß1 integrin is expressed in epithelia, along with {alpha}2ß1. However, the major function of {alpha}3ß1 may be as a laminin-5 receptor and not as a primary collagen receptor, although it may regulate collagen receptor function.13 For this reason, the finding that {alpha}3-deficient mice die shortly after birth because of kidney and lung dysfunction and the observation that they exhibit epidermal blistering may be attributed to the loss of laminin receptor function.14,15 The {alpha}10ß1 and {alpha}11ß1 integrins were identified relatively recently and data on their expression and function are limited.16-18 Mice deficient in either the {alpha}10 or {alpha}11 subunits have not been generated. The expression of both of these integrins, however, appears to be restricted to mesenchymal cells. {alpha}11ß1, in particular, is expressed on mesenchymal non-muscle cells in areas of highly organized interstitial collagen networks and it may play an important role in the organization and remodeling of these matrices during development.18 From the perspective of {alpha}2ß1 function, neither {alpha}10ß1 nor {alpha}11ß1 appear to be expressed on epithelial cells or cells of hematopoietic origin.

Discoidin domain receptors (DDR1 and DDR2) are receptor tyrosine kinases that function as collagen receptors.19 The engagement of these receptors with collagen matrices induces receptor tyrosine kinase activity, albeit with slow kinetics. Of interest, DDR1, similar to {alpha}2ß1, is highly expressed in epithelia, but DDR1-null mice have a more severe phenotype than do the {alpha}2-null mice.20 Although these mice are viable, the majority of mutant females are unable to reproduce because of improper blastocyst implantation. Those females that can reproduce are unable to lactate because of hyperproliferation and abnormal branching in the mammary glands. These data implicate DDR1 in branching morphogenesis, a function that has also been attributed to {alpha}2ß1.

Integrin Redundancy and Compensation in Null Mice

The subtle phenotype of the {alpha}2-null mice raises the issues of integrin redundancy and compensation. Loss of {alpha}2ß1 expression in specific tissues may not be manifested in a severe phenotype because the function of {alpha}2ß1 may be fulfilled by other integrins with similar properties. In principle, this issue can be addressed rigorously by the generation of tissue specific knockouts in which two or more integrin subunits have been "knocked-out." The generation of an {alpha}1/{alpha}2 integrin subunit deficient mouse would exemplify this approach. A related possibility is that the loss of {alpha}2ß1 expression is compensated for by an increase in the expression or function of a related integrin. This possibility needs to be assessed for the {alpha}2-null mice by careful examination of integrin expression patterns in specific tissues, especially epithelia.

Commentary on the Reported Phenotype of the {alpha}2-Deficient Mice

Aside from gross observations, the analysis of the {alpha}2-deficient mice to date has focused on the contribution of {alpha}2ß1 to platelet adhesion and hemostasis, branching morphogenesis, and epidermal wound healing.

Platelet Adhesion and Hemostasis

Numerous studies have indicated that {alpha}2ß1 mediates the adhesion of platelets to subendothelial collagen at sites of vessel injury and that GPVI, a low affinity co-receptor, mediates collagen-induced activation and aggregation of platelets.2 Analysis of platelets isolated from the {alpha}2-null mice supports this model. These {alpha}2-deficient platelets are unable to adhere to collagen I under either static or flow conditions but they are able to aggregate in response to collagen, albeit at a decreased rate. Interestingly, platelets isolated from {alpha}2+/- heterozygous mice exhibit a significant reduction in their ability to adhere to collagen, a finding that is consistent with the hypothesis that the extent of platelet adhesion to collagen is a function of the level of {alpha}2ß1 expression. As stated,4 the {alpha}2-/- and +/- mice "provide an animal model to evaluate the molecular mechanisms by which allelic differences in the {alpha}2 gene and different levels of the {alpha}2ß1 integrin expression are associated with increased risk of myocardial infarction, diabetic retinopathy, and stroke." Somewhat surprisingly, however, the {alpha}2-deficient mice exhibit normal tail vein bleeding times. Zutter et al4 suggest that other potent activators of platelets that are present at sites of vascular injury may compensate for the loss of {alpha}2ß1 function.

Branching Morphogenesis

The branched network of ducts in the mammary gland that is formed during puberty is a prime example of a fundamental process termed "branching morphogenesis."21,22 Although the mechanisms that underlie this process are not well understood, it likely involves the concerted contributions of cell proliferation and matrix remodeling (both basement membrane and interstitial collagen). A key role for {alpha}2ß1 in this process had been indicated by the observation that this integrin is highly expressed at sites of terminal duct branching in the developing mammary gland and lung.10 In addition, studies that mimic branching morphogenesis in vitro using three-dimensional collagen gels had observed that this morphogenesis is dependent on the expression and function of {alpha}2ß1.23,24 Analysis of the {alpha}2-/- mice revealed a significant decrease in the extent of ductal branching in the {alpha}2-/- mice compared to the wild-type mice but branched ducts still formed. Moreover, this decrease did not hinder the ability of these mice to lactate and nurse their young. The conclusion can be drawn from these data that {alpha}2ß1 facilitates branching morphogenesis in the mammary gland but that it is not essential for this process. The lungs of these mice have yet to be analyzed for defects in branching morphogenesis but the fact that these mice are healthy with no overt pulmonary problems suggests that any putative lung defect is not too severe.

The availability of mammary tissue from the {alpha}2-null mice, as well as from the DDR1-null mice, provides a wonderful opportunity to investigate the mechanism and division of labor between {alpha}2ß1 and DDR1 in mediating branching morphogenesis. Although the authors of both the {alpha}2-null and DDR1-null mice studies suggest that these receptors impact branching morphogenesis by regulating epithelial cell proliferation, the process of branching is much more complex and it also involves the ability of epithelial cells to contract, degrade, and remodel extracellular matrices. Analysis of the behavior of mammary epithelial cells isolated from these null mice in three-dimensional collagen gels will be insightful and provide a foundation for more mechanistic studies aimed at assessing the contribution of these receptors to cytoskeletal dynamics, regulation of matrix metalloprotease expression, and specific signaling pathways. Moreover, the finding that the mammary glands from the {alpha}2-null and DDR1-null mice have distinct morphological phenotypes (decreased branching versus abnormal branching) suggests that these two receptors regulate different aspects of the branching process. Indeed, the more severe phenotype of the DDR1-null mammary glands and the inability of these mice to lactate implicate a critical role for the tyrosine kinase activity of DDR1 in mammary gland development. In this direction, targeted deletion of both the {alpha}2 subunit and DDR1 in the mammary gland would be informative.

Epidermal Wound Healing

The {alpha}2ß1 integrin is expressed at relatively high levels in the basal cell layer of the skin and at moderate levels in dermal fibroblasts. Moreover, three-dimensional collagen matrices stimulate expression of the {alpha}2 subunit in dermal fibroblasts suggesting that {alpha}2ß1 may be involved in the contraction of these matrices that occurs during wound healing,25 and the migration of keratinocytes on collagen is blocked by the addition of {alpha}2-specific antibodies.26 Collectively, these data had implicated {alpha}2ß1 in the morphogenesis of the dermis and in wound healing. Studies on the {alpha}2-null mice, however, refute these predictions. The morphology of the dermis in the null mice is comparable to that of the wild-type mice, and full-thickness skin wounds in the {alpha}2-deficient mice heal as well as in the wild-type mice.

Can the in vitro and in vivo data on the role of {alpha}2ß1 in epidermal wound healing be reconciled? Zutter et al4 suggest that the {alpha}2-specific antibodies used to inhibit wound healing processes in vitro actually stimulate signaling pathways that impede these processes. More data are needed to support this hypothesis and the nature of the signaling pathways that impede wound healing need to be defined. Another possibility that should be considered is that loss of {alpha}2ß1 function is compensated for by an increase in the expression or functional capacity of another integrin collagen receptor as discussed above. For example, both the {alpha}10ß1 and {alpha}11ß1 integrins are expressed on fibroblasts and could mediate collagen gel contraction. Future studies on dermal fibroblasts and keratinocytes isolated from the {alpha}2-deficient mice should prove valuable in resolving these issues.

The Role of {alpha}2ß1 in Inflammation

Although the {alpha}2-deficient mice appear relatively healthy, their ability to respond to injury and infection has not been examined, with the exception of skin wounds. In fact, the {alpha}2ß1 integrin was identified initially as one of several antigens (including several integrins) that are expressed during the very late stages of T cell activation (VLA-2)27 but its specific contributions to T cell function are only beginning to be understood. The ability of {alpha}2ß1 to mediate leukocyte adhesion and extravasation from the vasculature into peripheral tissues suggests that it may play an important role in inflammation. This possibility is supported by the finding that monoclonal antibodies specific for {alpha}2, as well as for {alpha}1, inhibit effector phase inflammatory responses in animal models of delayed-type hypersensitivity, contact hypersensitivity, and arthritis.28 Also, {alpha}2ß1-mediated collagen interactions may inhibit Fas ligand expression and the activation-induced cell death that occurs during the late stages of T cell activation.29 Given that collagen I expression increases in many inflammatory and autoimmune diseases, {alpha}2ß1-mediated interactions with collagen I may impede apoptosis and result in hyperactivated T cells that have the potential to contribute to tissue damage. For these reasons, studies that use the {alpha}2-deficient mice in models of chronic inflammation should provide a more rigorous assessment of the {alpha}2ß1 contribution.

The Role of {alpha}2ß1 in Tumor Biology

Although decreased {alpha}2ß1 expression has been correlated with de-differentiation and tumor progression in the mammary gland,3 a causal link between {alpha}2ß1 and tumorigenesis has not been established. The finding that the {alpha}2-deficient mice exhibit decreased ductal branching presumably reflects a less differentiated phenotype that can be attributed to loss of {alpha}2ß1 function and it suggests the value of these mice for tumorigenesis studies. In addition, as alluded to above, detailed studies on mammary epithelial cells isolated from the {alpha}2-null mice could provide important clues into the mechanism by which {alpha}2ß1 contributes to epithelial differentiation.

A reasonable hypothesis based on the observations mentioned above is that the {alpha}2-deficient mice will be more prone to developing breast cancer than wild-type mice. This hypothesis can be tested by crossing the {alpha}2-null mice with one of the well-established transgenic models of mammary tumorigenesis. Mice that express erbB2, for example, require almost a year to develop breast tumors.30 One expectation would be that {alpha}2-null mice that express erbB2 develop tumors at a faster rate.

The {alpha}2ß1 integrin may also facilitate tumor progression through its contribution to angiogenesis. Senger and colleagues31,32 have highlighted an important role for both the {alpha}2ß1 and {alpha}1ß1 integrins in tumor angiogenesis and have suggested that these collagen receptors function in concert with other integrins to mediate distinct components of the angiogenic process. Although no gross defects in the vasculature of the {alpha}2-null mice were noted, the ability of tumor implanted in these mice to be vascularized needs to be examined. A similar experiment performed with the {alpha}1-null mice noted decreased vascularization with a significant reduction in capillary size and number.12 A comparison of the {alpha}2- and {alpha}1-null mice in this regard may provide clues into the relative contribution of {alpha}2ß1 and {alpha}1ß1 to angiogenesis.

Conclusion

The generation of an {alpha}2-deficient mouse has been eagerly anticipated by the integrin community because {alpha}2ß1, a founding member of the integrin family, is one of the most-studied integrins with respect to both structure and function. The finding that the {alpha}2-deficient mice are quite healthy may be disappointing to some. Indeed, their subtle phenotype implies that many of the key functions of {alpha}2ß1 can be mimicked by other integrin or non-integrin receptors, or compensated for by an increase in the expression or function of these receptors. The analysis of these mice is far from complete, however, especially with regard to the role of {alpha}2ß1 in pathogenesis. The importance of this integrin in chronic inflammation, tumorigenesis, and angiogenesis, for example, may be substantiated or challenged by studies using these mice. Moreover, their use in conjunction with other integrin- and DDR-null mice should provide insight into the relative contribution of these receptors to specific collagen-mediated functions.

Footnotes

Address reprint requests to Arthur M. Mercurio, Beth Israel Deaconess Medical Center, Research North, 330 Brookline Avenue, Boston, MA 02215. E-mail: amercuri{at}caregroup.harvard.edu

Supported by National Institutes of Health grant CA80789.

Accepted for publication May 2, 2002.

References

  1. Elices MJ, Hemler ME: The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci USA 1989, 86:9906-9910[Abstract/Free Full Text]
  2. Santoro SA: Platelet surface collagen receptor polymorphisms: variable receptor expression and thrombotic/hemorrhagic risk. Blood 1999, 93:3575-3577[Free Full Text]
  3. Zutter MM, Sun H, Santoro SA: Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors. J Mammary Gland Biol Neoplasia 1998, 3:191-200[Medline]
  4. Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM: The {alpha}2 integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 2002, 161:337-344[Abstract/Free Full Text]
  5. Holtkotter O, Nieswandt B, Smyth N, Muller W, Hafner M, Schulte V, Krieg T, Eckes B: Integrin {alpha}2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J Biol Chem 2002, 277:10789-10794[Abstract/Free Full Text]
  6. Heino J: The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 2000, 19:319-323[Medline]
  7. Liddington R, Bankston L: The integrin I domain: crystals, metals and related artefacts. Structure 1998, 6:937-938[Medline]
  8. Tulla M, Pentikainen OT, Viitasalo T, Kapyla J, Impola U, Nykvist P, Nissinen L, Johnson MS, Heino J: Selective binding of collagen subtypes by integrin {alpha}1I, {alpha}2I, and {alpha}10 I domains. J Biol Chem 2001, 276:48206-48212[Abstract/Free Full Text]
  9. Duband JL, Belkin AM, Syfrig J, Thiery JP, Koteliansky VE: Expression of {alpha}1 integrin, a laminin-collagen receptor, during myogenesis and neurogenesis in the avian embryo. Development 1992, 116:585-600[Abstract]
  10. Wu JE, Santoro SA: Complex patterns of expression suggest extensive roles for the {alpha}2ß1 integrin in murine development. Dev Dyn 1994, 199:292-314[Medline]
  11. Gardner H, Kreidberg J, Koteliansky V, Jaenisch R: Deletion of integrin {alpha}1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol 1996, 175:301-313[Medline]
  12. Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA: Elevated matrix metalloprotease and angiostatin levels in integrin {alpha}1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 2000, 97:2202-2207[Abstract/Free Full Text]
  13. Hodivala-Dilke KM, DiPersio CM, Kreidberg JA, Hynes RO: Novel roles for {alpha}3ß1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes. J Cell Biol 1998, 142:1357-1369[Abstract/Free Full Text]
  14. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R: {alpha}3ß1 integrin has a crucial role in kidney and lung organogenesis. Development 1996, 122:3537-3547[Abstract]
  15. DiPersio CM, Hodivala-Dilke KM, Jaenisch R, Kreidberg JA, Hynes RO: {alpha}3ß1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol 1997, 137:729-742[Abstract/Free Full Text]
  16. Camper L, Hellman U, Lundgren-Akerlund E: Isolation, cloning, and sequence analysis of the integrin subunit {alpha}10, a ß1-associated collagen binding integrin expressed on chondrocytes. J Biol Chem 1998, 273:20383-20389[Abstract/Free Full Text]
  17. Camper L, Holmvall K, Wangnerud C, Aszodi A, Lundgren-Akerlund E: Distribution of the collagen-binding integrin {alpha}10ß1 during mouse development. Cell Tissue Res 2001, 306:107-116[Medline]
  18. Tiger CF, Fougerousse F, Grundstrom G, Velling T, Gullberg D: {alpha}11ß1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal non-muscle cells. Dev Biol 2001, 237:116-129[Medline]
  19. Vogel W: Discoidin domain receptors: structural relations and functional implications. EMBO J 1999, 13(Suppl):S77-S82
  20. Vogel WF, Aszodi A, Alves F, Pawson T: Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 2001, 21:2906-2917[Abstract/Free Full Text]
  21. Sekhri KK, Pitelka DR, DeOme KB: Studies of mouse mammary glands: I. cytomorphology of the normal mammary gland. J Natl Cancer Inst 1967, 39:459-490
  22. Berdichevsky F, Alford D, D’Souza B, Taylor-Papadimitriou J: Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci 1994, 107:3557-3568[Abstract]
  23. Keely PJ, Fong AM, Zutter MM, Santoro SA: Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense {alpha}2 integrin mRNA in mammary cells. J Cell Sci 1995, 108:595-607[Abstract]
  24. Zutter MM, Santoro SA, Staatz WD, Tsung YL: Re-expression of the {alpha}2ß1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 1995, 92:7411-7415[Abstract/Free Full Text]
  25. Xu J, Zutter MM, Santoro SA, Clark RA: A three-dimensional collagen lattice activates NF-{kappa}B in human fibroblasts: role in integrin {alpha}2 gene expression and tissue remodeling. J Cell Biol 1998, 140:709-719[Abstract/Free Full Text]
  26. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC: The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997, 137:1445-1457[Abstract/Free Full Text]
  27. Hemler ME: VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990, 8:365-400[Medline]
  28. de Fougerolles AR, Sprague AG, Nickerson-Nutter CL, Chi-Rosso G, Rennert PD, Gardner H, Gotwals PJ, Lobb RR, Koteliansky VE: Regulation of inflammation by collagen-binding integrins {alpha}1ß1 and {alpha}2ß1 in models of hypersensitivity and arthritis. J Clin Invest 2000, 105:721-729[Medline]
  29. Aoudjit F, Vuori K: Engagement of the {alpha}2ß1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner. Blood 2000, 95:2044-2051[Abstract/Free Full Text]
  30. Dankort DL, Muller WJ: Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene 2000, 19:1038-1044[Medline]
  31. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M: Angiogenesis promoted by vascular endothelial growth factor: regulation through {alpha}1ß1 and {alpha}2ß1 integrins. Proc Natl Acad Sci USA 1997, 94:13612-13617[Abstract/Free Full Text]
  32. Senger DR, Perruzzi CA, Streit M, Koteliansky VE, de Fougerolles AR, Detmar M: The {alpha}1ß1and {alpha}2ß1 integrins provide critical support for vascular endothelial growth: factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 2002, 160:195-204[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Stem CellsHome page
A. Pajoohesh-Ganji, S. Pal-Ghosh, S. J. Simmens, and M. A. Stepp
Integrins in Slow-Cycling Corneal Epithelial Cells at the Limbus in the Mouse
Stem Cells, April 1, 2006; 24(4): 1075 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Sanz, R.-Q. Chen, A. Perez, R. Hilario, P. Juarez, C. Marcinkiewicz, D. Monleon, B. Celda, Y.-L. Xiong, E. Perez-Paya, et al.
cDNA Cloning and Functional Expression of Jerdostatin, a Novel RTS-disintegrin from Trimeresurus jerdonii and a Specific Antagonist of the {alpha}1{beta}1 Integrin
J. Biol. Chem., December 9, 2005; 280(49): 40714 - 40722.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Kaido, M. Yebra, V. Cirulli, and A. M. Montgomery
Regulation of Human {beta}-Cell Adhesion, Motility, and Insulin Secretion by Collagen IV and Its Receptor {alpha}1{beta}1
J. Biol. Chem., December 17, 2004; 279(51): 53762 - 53769.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mercurio, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mercurio, A. M.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS